These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38756875)

  • 1. Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China.
    Li C; Zhou T; Zhang P; He J; Liu Y
    Front Public Health; 2024; 12():1394762. PubMed ID: 38756875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
    Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
    Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Mukherjee A; Anand T; Agarwal A; Singh H; Chatterjee P; Narayan J; Rana S; Gupta N; Bhargava B; Panda S
    Epidemiol Infect; 2021 Mar; 149():e82. PubMed ID: 33766185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of SARS-CoV-2 vaccination on the epidemiological and clinical characteristics of imported COVID-19 cases in Chengdu].
    Yue Y; Liang X; Mao Y; Hu M; Han DL; Su LY; Chen H; Fan SF; Zhang XC; Yang F; Yuan QW; Liu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1365-1370. PubMed ID: 34814555
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical characteristics of children with Omicron variant infection in Chengdu area, China].
    Jiang J; Yang M; Li DY; Qiao LN; Zhang HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):849-854. PubMed ID: 37668034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
    Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
    BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 re-infection risk in Austria.
    Pilz S; Chakeri A; Ioannidis JP; Richter L; Theiler-Schwetz V; Trummer C; Krause R; Allerberger F
    Eur J Clin Invest; 2021 Apr; 51(4):e13520. PubMed ID: 33583018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
    Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
    J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study.
    Ma X; Wang Z; Chen Y; Li Z
    BMC Infect Dis; 2024 Mar; 24(1):354. PubMed ID: 38539124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Cases of Sars-cov-2 Reinfection Coinciding with the Covid-19 Second Wave, Benin City, Nigeria.
    Okwara BU; Osaigbovo II; Ogboghodo EO; Adio F; Oduware E; Obaseki DE; Asamah D
    West Afr J Med; 2022 Aug; 39(8):777-780. PubMed ID: 36057812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
    Zheng S; Fan J; Yu F; Feng B; Lou B; Zou Q; Xie G; Lin S; Wang R; Yang X; Chen W; Wang Q; Zhang D; Liu Y; Gong R; Ma Z; Lu S; Xiao Y; Gu Y; Zhang J; Yao H; Xu K; Lu X; Wei G; Zhou J; Fang Q; Cai H; Qiu Y; Sheng J; Chen Y; Liang T
    BMJ; 2020 Apr; 369():m1443. PubMed ID: 32317267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.